Recombinant human erythropoietin reduces aggregation of mutant Cu/Zn-binding superoxide dismutase (SOD1) in NSC-34 cells.

doi:10.1016/j.neulet.2011.09.008

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Recombinant human erythropoietin reduces aggregation of mutant Cu/Zn-binding superoxide dismutase (SOD1) in NSC-34 cells.

Neuroscience letters - 24 Oct 2011

Cho Goang-Won, Kim Ga-Young, Baek Soojeong, Kim Heejaung, Kim Taikon, Kim Hee Jin, Kim Seung Hyun

Abstract excerpt

Human erythropoietin (hEPO) has multiple actions in non-hematopoietic tissues, including neurotrophic, anti-oxidant, anti-apoptotic, and anti-inflammatory effects. To examine the effect of EPO in an vitro model of amyotrophic lateral sclerosis (ALS), we stably overexpressed wild SOD1 and a mutant form, SOD1/G93A, in NSC-34 motoneuron-like cells. Transformants harboring the wild and mutant forms of SOD1 were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antimetabolites
Share to Bromodeoxyuridine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Choline O-Acetyltransferase

Share to Cyclooxygenase 2

Share to Erythropoietin

Share to Motor Neurons

Share to Oligonucleotides

Share to Superoxide Dismutase

Source

Open in PubMed

Identifiers

PMID: 21945651
DOI: 10.1016/j.neulet.2011.09.008

Genes

SOD1
EPO

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.